Effects of Chronic Right Ventricular Pacing in Children With Advanced Atrioventricular Block
NCT ID: NCT01477658
Last Updated: 2013-05-07
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
140 participants
OBSERVATIONAL
2007-11-30
2013-11-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Thus, our aims is to assess the chronic effects of cardiac pacing in children and young patients with advanced AVB and its impact on clinical, functional and echocardiographic parameters.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Exercise in Chronically Paced Children
NCT00374608
Cohort Description of Younger With AV-block
NCT03024047
Synchrony in Cardiac Conduction: Assessing the Effects of Pacing on Cardiac Performance Through Magnetic Resonance Imaging and Advanced ECG-imaging
NCT06843135
Left Bundle Branch Pacing Versus Right Ventricular Pacing in Patients With Atrioventricular Block
NCT05722379
Biventricular Pacing in the Pediatric Population
NCT00267423
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The design of the study will involve the following stages:
1. Screening and enrollment: patients will be selected consecutively during ambulatory care at our Institution or by the database of the Surgical Unity of Cardiac Pacing;
2. Clinical and laboratory evaluation: patient history, clinical evaluation, serum levels of neurohormonal and inflammatory biomarkers of heart failure, clinical and laboratory investigation of autoimmune rheumatic diseases, quality of life (SF-36, CHQ-PF50) and six-minute walk test;
3. Evaluation of ventricular function and cardiac synchronicity: Tissue Doppler (TDI) and real-time three-dimensional echocardiography (RT3DE);
4. Follow-up: patients will be monitored during 24 months.
The main end-points are:
* Clinical and functional changes (NYHA functional class)
* Heart failure hospitalization
* Quality of life
* Overall and cardiac mortality
* Cardiac resynchronization therapy and heart transplantation
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Congenital AV Block
Patients diagnosed with Congenital Complete Atrioventricular Heart Block
No interventions assigned to this group
Postoperative AV Block
Patients diagnosed with postoperative AV block
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Advanced AV block with /without congenital heart defects
* Time under cardiac pacing superior than one year
* Unicameral or atrioventricular pacing in single right ventricle site
* Informed consent of the patient or responsible
Exclusion Criteria
* Discontinuing use of the device for recovery of atrioventricular conduction
* Cardiac transplantation
* Inability to participate in the study procedures
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Sao Paulo
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Roberto Costa
Associated Professor of Cardiovascular Surgery
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Roberto Costa, MD, PhD
Role: STUDY_CHAIR
University of Sao Paulo
Roberto M Oliveira Jr, MD
Role: PRINCIPAL_INVESTIGATOR
University of Sao Paulo
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Heart Institute (InCor) of University of São Paulo Medical School (Brazil)
São Paulo, São Paulo, Brazil
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CAPPesq nº 1248/09
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.